January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The emerging need for oral medicines is due to the progression of diabetes, inadequate lifestyle management, and declining insulin production. North America dominated the market in 2024, driven by the growing aging population, innovative drug treatments, and improved access and affordability....
April 21, 2026
Based on market forecasts, the global human growth hormone injection market, projected at USD 4.53 billion in 2025, is expected to reach USD 8.54 billion by 2035, growing at a CAGR of 6.55% over the forecast period. The human growth hormone injection market is growing as approval of this hormone for healthcare applications and extensive, controvers...
April 21, 2026
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North America led the global market owing to a strong R&D pipeline & biopharmaceutical innovations in ...
April 21, 2026
Projections indicate that, the global brain health supplements market will increase from USD 12.6 billion in 2025 to USD 35.94 billion by 2035, experiencing a CAGR of 11.05% over the next 10 years. The market is growing due to rising awareness about cognitive wellness, aging populations, and increasing demand for memory and focus enhancement produc...
April 21, 2026
Market insights predict, the liquid health supplements industry is expected to grow from USD 24.12 billion in 2024 to USD 73.42 billion by 2034, driven by a CAGR of 11.65%. The liquid health supplements market is on the rise due to rising awareness about health supplements among consumers in fitness communities. North America dominates the market d...
April 21, 2026
Based on market forecasts, the global pharmaceutical grade melatonin market, projected at USD 479.9 million in 2024, is expected to reach USD 1044.3 million by 2034, growing at a CAGR of 8.56% over the forecast period. The rising prevalence of sleep disorders and the burgeoning tourism sector drive the global market. The presence of key players and...
April 21, 2026
Based on market forecasts, the global veterinary biological product market, projected at USD 17.9 billion in 2024, is expected to reach USD 25.9 billion by 2034, growing at a CAGR of 3.78% over the forecast period. The critical role of veterinary products in diagnosis, disease prevention, treatment, and therapeutic interventions makes them pivotal ...
April 21, 2026
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPPS, hybrid), product types (reagents, consumables, services), end-users (pharma, CDMOs/CROs), and app...
April 21, 2026
The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North America (45.9%) and Asia Pacific. The study covers trade data, supply chain, key players like QIAGEN,...
April 21, 2026
The nanobiotechnology market was valued at USD 172.81 billion in 2024 and is projected to reach USD 420.2 billion by 2034, growing at a CAGR of 9.37%. The report covers segments by material, product type, and end-user, with regional insights across North America (42%), Europe, APAC, Latin America, and MEA. It includes value chain and competitive an...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com